|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 39/12 | (2006.01) |
| A61K 47/00 | (2006.01) | ||
| A61P 31/20 | (2006.01) |
| (11) | Number of the document | 1150712 |
| (13) | Kind of document | T |
| (96) | European patent application number | 00905886.8 |
| Date of filing the European patent application | 2000-02-01 | |
| (97) | Date of publication of the European application | 2001-11-07 |
| (45) | Date of publication and mention of the grant of the patent | 2008-11-05 |
| (46) | Date of publication of the claims translation | 2009-02-25 |
| (86) | Number | PCT/US2000/002463 |
| Date | 2000-02-01 |
| (87) | Number | WO 2000/045841 |
| Date | 2000-08-10 |
| (30) | Number | Date | Country code |
| 118723 P | 1999-02-05 | US |
| (72) |
VOLKIN, David, B., US
SHI, Li, US
MACH, Henryk, US
|
| (73) |
MERCK SHARP & DOHME CORP.,
126 East Lincoln Avenue, Rahway, New Jersey 07065,
US
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Žmogaus papilomos viruso kompozicijos |
| HUMAN PAPILLOMA VIRUS VACCINE FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2019-01-29 | 20 | 347.00 EUR |